Games Workshop Shares Surge After Fed Holds Interest Rates
Nottingham-based Games Workshop enjoys stock boost as Federal Reserve holds interest rates, sparking global market rally and boosting UK retail investments.
Category : Search result: UK pharmaceutical companies
Sewage Sleuths Expose Toxic Truth About UK River Crisis
An explosive investigation by determined citizen scientists reveals how systemic sewage dumping by water companies is causing the slow, dirty death of rivers across England and Wales, with regulators accused of turning a blind eye.
New Weight Loss Pill Cuts Body Weight By 20%
Breakthrough obesity drug Orforglipron shows unprecedented results in clinical trials, reducing body weight by a fifth and offering new hope for millions struggling with weight management in the UK.
NHS Must Reverse Medicines Investment Decline - Minister
Former chief scientific adviser Sir Patrick Vallance warns that dwindling investment in medical research and innovation threatens the future of the NHS and patient care. Discover the urgent call for action.
AstraZeneca shifts cancer drug production from UK to Ireland
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Private parking tickets surge 24% hitting UK drivers
British motorists are facing a record onslaught of private parking tickets, with a shocking 24% annual surge in charges. Discover the data behind the £100M industry and how to fight back.
Trump Threatens NHS Drug Pricing: UK Faces US Medicine Costs
Exclusive analysis reveals how a potential Trump presidency could jeopardise Britain's NHS medicine pricing, forcing UK patients to pay US-style pharmaceutical costs.
6,000 Hours of Sewage Pollutes UK National Parks
Shocking new data reveals sewage was pumped into the rivers and lakes of Britain's most treasured national parks for thousands of hours last year, with the Lake District and Snowdonia among the worst hit.
Big Pharma's Billion-Pound Bet on Post-Trump UK
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
UK Firms Harass Bereaved Families for Payments, Report Finds
A damning report reveals UK companies are failing bereaved customers, with families harassed for payments and forced through complex 'death admin' while grieving.
Thames Water paid £1m+ to firm part-owned by Starmer adviser
Exclusive: Troubled utility giant Thames Water paid over £1 million to a corporate intelligence firm co-owned by a key adviser to Keir Starmer, raising serious questions about conflicts of interest and corporate governance.
AstraZeneca Pauses £500m Cambridge HQ Investment
Pharmaceutical giant AstraZeneca has paused plans for its new £500 million global headquarters in Cambridge, citing an 'unfavourable' UK economic climate and sending shockwaves through the business community.
US Scraps Mandatory Corporate Greenhouse Gas Reporting
In a major environmental policy reversal, the Trump administration has abolished a mandate requiring large US companies to disclose their greenhouse gas emissions. Critics warn this decision blindsides investors and undermines global climate efforts.
Lord Mandelson's Secret Millions Exposed in Court Battle
An explosive legal dispute has laid bare former Labour minister Lord Mandelson's relentless pursuit of wealth, revealing a life of luxury funded by a complex web of offshore dealings and multi-million pound loans.
Common Meds Linked to Youth Suicide Surge, Study Finds
Groundbreaking research uncovers a disturbing correlation between widely prescribed drugs, including beta-blockers and anti-anxiety medications, and a sharp increase in suicide risks and depression in children and young adults. Experts are calling for urg
AstraZeneca Pauses £200m Cambridge Research Investment
Pharmaceutical giant AstraZeneca pauses its major £200m Cambridge research centre expansion, citing global strategic review and UK economic uncertainty in post-Brexit landscape.
Sanofi CEO: UK is 'terrible place' for medicines
Sanofi executive warns of UK's worsening medicines access crisis, citing post-Brexit regulations, NICE hurdles, and a pricing system that deters investment and innovation.
MSD to create 125+ new R&D jobs in London expansion
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
Trump pressured FDA to fast-track Covid vaccine before election
Exclusive report reveals Donald Trump pressured US health officials to accelerate vaccine approval for political gain ahead of the 2020 election, according to congressional investigation.
Fossil Fuel Firms Profit €100BN From Deadly Heatwaves
A damning new report exposes how major fossil fuel companies are reaping enormous profits while Europe bakes in record-breaking, climate-driven heatwaves, leading to thousands of preventable deaths.
Mounjaro KwikPens launch without price reduction
Exclusive: Diabetes and weight loss patients face financial strain as Eli Lilly's new Mounjaro KwikPens hit the market without the anticipated price reduction, maintaining a premium cost for the identical medication.
Congress Grills Pharma Over Child Vaccine-Linked Illnesses
A tense US Congressional hearing investigates a surge in severe neurological illnesses in children following vaccination, as lawmakers demand answers from pharmaceutical executives.
Wegovy Jab Sends Novo Nordisk Shares Soaring Past £400bn
Danish pharmaceutical giant Novo Nordisk's market value skyrockets past £400bn, briefly eclipsing the entire Danish economy, on the back of soaring demand for its blockbuster weight-loss drug, Wegovy.
Falmouth's 'Third World' Sewage Crisis: A National Scandal
The picturesque port town of Falmouth, a jewel in Cornwall's crown, is facing an environmental disaster as raw sewage repeatedly floods streets and homes, with residents and officials branding the situation a 'national scandal'.
Germany seizes illegal Wegovy shipment in Frankfurt
German authorities have confiscated thousands of doses of the in-demand weight-loss medication Wegovy from a Frankfurt wholesaler, citing illegal parallel imports from outside the EU and improper storage conditions.
Tech Giants Accused of Brazen Theft of Creative Works for AI
Leading tech firms are facing allegations of systematic copyright theft, using protected creative works to train AI without permission or compensation. This investigation reveals the scale of the digital pillaging.
Water companies fined £500k for customer service failures
UK water regulators have slapped two major suppliers with hefty fines totalling over half a million pounds for severe customer service and complaints handling failures, impacting vulnerable households across England.
Thames Water Delays £7.5m Charity Payment Amid Crisis
Thames Water postpones £7.5m charity payment as financial pressures mount, sparking outrage from environmental groups and raising fresh concerns over the utility giant's stability.
Teen dies after starting new asthma medication
A 13-year-old girl from Northern Ireland tragically passed away just days after being prescribed a new asthma medication. Her devastated family is now demanding answers from health authorities.
New heart drug fails to outperform aspirin in major trial
Groundbreaking medical research reveals a new anti-inflammatory drug shows no significant advantage over traditional aspirin for heart attack prevention in most patients, challenging pharmaceutical expectations.
Page 1 of 4